Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structure-Guided Screening for Functionally Selective D2 Dopamine Receptor Ligands from a Virtual Chemical Library
Barbara Männel, Mariama Jaiteh, Alexey A. Zeifman, et al.
ACS Chemical Biology (2017) Vol. 12, Iss. 10, pp. 2652-2661
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

G protein-coupled receptors: structure- and function-based drug discovery
Dehua Yang, Qingtong Zhou, Viktorija Labroska, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 425
A practical guide to large-scale docking
Brian J. Bender, Stefan Gahbauer, Andreas Luttens, et al.
Nature Protocols (2021) Vol. 16, Iss. 10, pp. 4799-4832
Open Access | Times Cited: 376
Virtual discovery of melatonin receptor ligands to modulate circadian rhythms
Reed M. Stein, Hye Jin Kang, John D. McCorvy, et al.
Nature (2020) Vol. 579, Iss. 7800, pp. 609-614
Open Access | Times Cited: 277
In silico Strategies to Support Fragment-to-Lead Optimization in Drug Discovery
Lauro Ribeiro de Souza Neto, José Teófilo Moreira-Filho, Bruno J. Neves, et al.
Frontiers in Chemistry (2020) Vol. 8
Open Access | Times Cited: 200
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Flavio Ballante, Albert J. Kooistra, Stefanie Kampen, et al.
Pharmacological Reviews (2021) Vol. 73, Iss. 4, pp. 1698-1736
Open Access | Times Cited: 104
Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity
Kelly A. Berg, William P. Clarke
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 10, pp. 962-977
Open Access | Times Cited: 135
Haloperidol bound D2 dopamine receptor structure inspired the discovery of subtype selective ligands
Luyu Fan, Liang Tan, Zhangcheng Chen, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 93
Property-Unmatched Decoys in Docking Benchmarks
Reed M. Stein, Yang Ying, Trent E. Balius, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 2, pp. 699-714
Open Access | Times Cited: 93
The compromise of virtual screening and its impact on drug discovery
Olivia Slater, Maria Kontoyianni
Expert Opinion on Drug Discovery (2019) Vol. 14, Iss. 7, pp. 619-637
Open Access | Times Cited: 78
2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts
Amy Hauck Newman, Francisco O. Battiti, Alessandro Bonifazi
Journal of Medicinal Chemistry (2019) Vol. 63, Iss. 5, pp. 1779-1797
Open Access | Times Cited: 62
Rational design of agonists for bitter taste receptor TAS2R14: from modeling to bench and back
Antonella Di Pizio, Lukas Waterloo, Regine Brox, et al.
Cellular and Molecular Life Sciences (2019) Vol. 77, Iss. 3, pp. 531-542
Open Access | Times Cited: 58
Strategies for the discovery of biased GPCR ligands
Marcel Bermúdez, Trung Ngoc Nguyen, Christian Omieczynski, et al.
Drug Discovery Today (2019) Vol. 24, Iss. 4, pp. 1031-1037
Closed Access | Times Cited: 47
Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity
Mariama Jaiteh, Ismael Rodríguez‐Espigares, Jana Selent, et al.
PLoS Computational Biology (2020) Vol. 16, Iss. 3, pp. e1007680-e1007680
Open Access | Times Cited: 38
Ligand-Induced Biased Activation of GPCRs: Recent Advances and New Directions from In Silico Approaches
Shaima Hashem, Alexis Dougha, Pierre Tufféry
Molecules (2025) Vol. 30, Iss. 5, pp. 1047-1047
Open Access
Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space
Axel Rudling, Robert Gustafsson, Ingrid Almlöf, et al.
Journal of Medicinal Chemistry (2017) Vol. 60, Iss. 19, pp. 8160-8169
Closed Access | Times Cited: 37
A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods
Beatriz Bueschbell, Carlos A.V. Barreto, António J. Preto, et al.
Molecules (2019) Vol. 24, Iss. 7, pp. 1196-1196
Open Access | Times Cited: 31
Emulating Docking Results Using a Deep Neural Network: A New Perspective for Virtual Screening
Stanisław Jastrzȩbski, Maciej Szymczak, Agnieszka Pocha, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 9, pp. 4246-4262
Closed Access | Times Cited: 30
Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?
Jon Kapla, Ismael Rodríguez‐Espigares, Flavio Ballante, et al.
PLoS Computational Biology (2021) Vol. 17, Iss. 5, pp. e1008936-e1008936
Open Access | Times Cited: 26
Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders
Radomír Jůza, Kamil Musílek, Eva Mezeiová, et al.
Medicinal Research Reviews (2022) Vol. 43, Iss. 1, pp. 55-211
Closed Access | Times Cited: 17
Allosteric Modulators of Dopamine D2 Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
Agnieszka A. Kaczor, Tomasz M. Wróbel, Damian Bartuzi
Molecules (2022) Vol. 28, Iss. 1, pp. 178-178
Open Access | Times Cited: 11
D2 Dopamine Receptor G Protein-Biased Partial Agonists Based on Cariprazine
Yudao Shen, John D. McCorvy, Michael L. Martini, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 9, pp. 4755-4771
Open Access | Times Cited: 18
Dopamine D2 Receptor Supersensitivity as a Spectrum of Neurotoxicity and Status in Psychiatric Disorders
Richard M. Kostrzewa, Karolina Wydra, Małgorzata Filip, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 366, Iss. 3, pp. 519-526
Open Access | Times Cited: 18
Controlling receptor function from the extracellular vestibule of G-protein coupled receptors
Attila Egyed, Katalin Domány-Kovács, Bence Koványi, et al.
Chemical Communications (2020) Vol. 56, Iss. 91, pp. 14167-14170
Open Access | Times Cited: 15
The Beta-Arrestin-Biased Dopamine D2 Receptor Ligand, UNC9994, Is a Partial Agonist at G-Protein-Mediated Potassium Channel Activation
Richard Ågren, Peter Århem, Johanna Nilsson, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 12, pp. 1102-1108
Open Access | Times Cited: 15
Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance
Ankita Punetha, Keith Green, Atefeh Garzan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 11, pp. 1894-1909
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top